Altshuler Shaham LTD Pacira Bio Sciences, Inc. Transaction History

Altshuler Shaham LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$51.49 - $81.64 $3,552 - $5,633	-69 Reduced 12.83%	469 $27,000
Q1 2022 May 16, 2022	BUY	$60.03 - $76.49 $32,296 - $41,151	538 New	538 $41,000
Q4 2020 Feb 16, 2021	SELL	$50.47 - $66.26 $21,399 - $28,094	-424 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$51.97 - $63.0 $883 - $1,071	17 Added 4.18%	424 $25,000
Q2 2020 Aug 13, 2020	BUY	$30.8 - $52.47 $12,535 - $21,355	407 New	407 $21,000

258

49.4M

1.03M

139K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.19B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.